|Articles|May 1, 2003

No Differences

San Francisco - Alefacept (Amevive) offers efficacy for a broad spectrum of patients with chronic plaque psoriasis who are considered candidates for systemic therapy or phototherapy, according to the results of a retrospective study.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Latest CME